Literature DB >> 16895524

Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Yutaka Maeda1, Wendy W Hwang-Verslues, Gang Wei, Takuya Fukazawa, Mary L Durbin, Laurie B Owen, Xuan Liu, Frances M Sladek.   

Abstract

The liver is exposed to a wide variety of toxic agents, many of which damage DNA and result in increased levels of the tumour suppressor protein p53. We have previously shown that p53 inhibits the transactivation function of HNF (hepatocyte nuclear factor) 4alpha1, a nuclear receptor known to be critical for early development and liver differentiation. In the present study we demonstrate that p53 also down-regulates expression of the human HNF4alpha gene via the proximal P1 promoter. Overexpression of wild-type p53 down-regulated endogenous levels of both HNF4alpha protein and mRNA in Hep3B cells. This decrease was also observed when HepG2 cells were exposed to UV irradiation or doxorubicin, both of which increased endogenous p53 protein levels. Ectopically expressed p53, but not a mutant p53 defective in DNA binding (R249S), down-regulated HNF4alpha P1 promoter activity. Chromatin immunoprecipitation also showed that endogenous p53 bound the HNF4alpha P1 promoter in vivo after doxorubicin treatment. The mechanism by which p53 down-regulates the P1 promoter appears to be multifaceted. The down-regulation was partially recovered by inhibition of HDAC activity and appears to involve the positive regulator HNF6alpha. p53 bound HNF6alpha in vivo and in vitro and prevented HNF6alpha from binding DNA in vitro. p53 also repressed stimulation of the P1 promoter by HNF6alpha in vivo. However, since the R249S p53 mutant also bound HNF6alpha, binding HNF6alpha is apparently not sufficient for the repression. Implications of the p53-mediated repression of HNF4alpha expression in response to cellular stress are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895524      PMCID: PMC1652821          DOI: 10.1042/BJ20060614

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Authors:  Y Nie; H H Li; C M Bula; X Liu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver.

Authors:  P E Ganey; F C Kauffman; R G Thurman
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

3.  Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone.

Authors:  O Lahuna; M Rastegar; D Maiter; J P Thissen; F P Lemaigre; G G Rousseau
Journal:  Mol Endocrinol       Date:  2000-02

4.  p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE.

Authors:  G Liu; J A Schwartz; S C Brooks
Journal:  Biochem Biophys Res Commun       Date:  1999-10-22       Impact factor: 3.575

5.  Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

Authors:  F M Sladek; W M Zhong; E Lai; J E Darnell
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

6.  Metallothionein acts as a cytoprotectant against doxorubicin toxicity.

Authors:  T Kimura; I Fujita; N Itoh; N Muto; T Nakanishi; K Takahashi; J Azuma; K Tanaka
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

7.  The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Authors:  X Liu; C W Miller; P H Koeffler; A J Berk
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver.

Authors:  Nadège Briançon; Alain Bailly; Frédéric Clotman; Patrick Jacquemin; Frédéric P Lemaigre; Mary C Weiss
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

10.  p53 involvement in the pathogenesis of fatty liver disease.

Authors:  Naoya Yahagi; Hitoshi Shimano; Takashi Matsuzaka; Motohiro Sekiya; Yuho Najima; Sachiko Okazaki; Hiroaki Okazaki; Yoshiaki Tamura; Yoko Iizuka; Noriyuki Inoue; Yoshimi Nakagawa; Yoshinori Takeuchi; Ken Ohashi; Kenji Harada; Takanari Gotoda; Ryozo Nagai; Takashi Kadowaki; Shun Ishibashi; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  23 in total

1.  Role of hepatocyte nuclear factor 4α in controlling copper-responsive transcription.

Authors:  Min Ok Song; Jonathan H Freedman
Journal:  Biochim Biophys Acta       Date:  2010-09-27

Review 2.  HNF4α--role in drug metabolism and potential drug target?

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

3.  Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition.

Authors:  Zhihong Yang; Yuxia Zhang; Li Wang
Journal:  Biochem Biophys Res Commun       Date:  2011-12-16       Impact factor: 3.575

4.  Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation.

Authors:  Zhi Wen; Dohun Pyeon; Yidan Wang; Paul Lambert; Wei Xu; Paul Ahlquist
Journal:  Mol Cell Biol       Date:  2011-10-24       Impact factor: 4.272

Review 5.  Regulation of hepatocyte identity and quiescence.

Authors:  Carmen Berasain; Matías A Avila
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

Review 6.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

7.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

8.  Differential Effects of Hepatocyte Nuclear Factor 4α Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human Colorectal Cancer Cells.

Authors:  Linh M Vuong; Karthikeyani Chellappa; Joseph M Dhahbi; Jonathan R Deans; Bin Fang; Eugene Bolotin; Nina V Titova; Nate P Hoverter; Stephen R Spindler; Marian L Waterman; Frances M Sladek
Journal:  Mol Cell Biol       Date:  2015-08-03       Impact factor: 4.272

9.  The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4α.

Authors:  Frances M Sladek
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

10.  p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation.

Authors:  Bi-He Cai; Pei-Ching Hsu; I-Lun Hsin; Chung-Faye Chao; Mei-Hua Lu; Hwang-Chi Lin; Shih-Hwa Chiou; Pao-Luh Tao; Jang-Yi Chen
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.